Vitamin K2 is the overlooked nutrient that may protect your bones and heart

Vitamin K2 is the overlooked nutrient that may protect your bones and heart
Image: Intellect (generated)

In short: While vitamin K1 is famous for blood clotting, its sibling K2 is gaining attention for its potential to improve bone density and cardiovascular health. Because K2 has a longer molecular chain, it lingers in the body longer than K1, offering unique benefits that researchers are only beginning to understand.

Vitamin K is a class of fat-soluble compounds rather than a single nutrient. While K1 (phylloquinone) is primarily found in leafy greens, K2 (menaquinone) is typically sourced from fermented foods and animal products. K2 is further categorized into subtypes ranging from MK-4 to MK-13, defined by the number of isoprene units in their side chains. This structural difference dictates how the body absorbs and utilizes each form.

The primary function of K vitamins is to activate Gla-proteins, which are essential for blood homeostasis and bone formation. Specifically, vitamin K2 helps activate osteocalcin, a protein that binds calcium to build bone mass. In parts of Asia, the MK-4 subtype is even utilized as a clinical treatment for osteoporosis. Beyond bones, K2 plays a critical role in heart health by activating proteins that prevent calcium from depositing in arterial walls, a process that can otherwise lead to dangerous calcification and cardiovascular disease.

Research into K2 is evolving rapidly, though much remains contested. Some studies suggest that K2 may be more effective than K1 at clearing arterial calcium, with one study indicating that higher dietary intake of K2 correlates with a lower risk of heart disease. However, clinical data comparing K2 supplementation directly to K1 remains inconclusive. While animal models, such as a 28-day study on rats, show promise in reducing cartilage degeneration, human trials are still ongoing to determine the full extent of its therapeutic potential.

It is important to note that the body’s ability to synthesize certain K2 subtypes is complex. While tissues can convert K1 into MK-4, long-chain menaquinones like MK-7 are primarily produced by bacteria. Despite the growing interest in K2, regulatory bodies like the U.S. Food and Drug Administration have yet to authorize specific health claims for it, distinguishing it from the established consensus on K1’s role in coagulation.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-vitamin-k2.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…